SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Sep 28, 2018

Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Sept. 28, 2018 · CIK: 0001585608 · Accession: 0001104659-18-059408

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-227292

Date
September 28, 2018
Author
Lisa A. Conte
Form
CORRESP
Company
Jaguar Health, Inc. (JAGX) (CIK 0001585608)

Letter

Re: Jaguar Health, Inc. Registration Statement on Form S-1

September 28, 2018

Via Email and EDGAR

Jeffrey Gabor U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549

Filed on September 12, 2018 and amended on September 28, 2018 File No. 333-227292

Ladies and Gentlemen:

Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on Monday, October 1, 2018, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.

Please confirm effectiveness by advising our counsel, Donald C. Reinke of Reed Smith LLP, at (650) 352-0532.

Very truly yours,
Jaguar Health, Inc.

Show Raw Text
CORRESP
1
filename1.htm

September 28, 2018

Via Email and EDGAR

Jeffrey Gabor
 U.S. Securities and Exchange Commission
 100 F Street, N.E.
 Washington, D.C. 20549

Re:                             Jaguar Health, Inc.
 Registration Statement on Form S-1

Filed on September 12, 2018 and amended on September 28, 2018
 File No. 333-227292

Ladies and Gentlemen:

Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on Monday, October 1, 2018, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.

Please confirm effectiveness by advising our counsel, Donald C. Reinke of Reed Smith LLP, at (650) 352-0532.

Very truly yours,

Jaguar Health, Inc.

/s/ Lisa A. Conte

Lisa A. Conte

Chief Executive Officer   and President

Jaguar Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105

Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · https://jaguar.health